Related by context. All words. (Click for frequent words.) 73 ICAAC 71 ICAAC IDSA 71 AACR NCI EORTC 70 ARVO 69 ECTRIMS 69 CROI 69 EASL 69 ASCO Annual Meeting 69 ADA Scientific Sessions 68 ACR ARHP 68 Gastrointestinal Cancers Symposium 68 ASCO 67 ASCO GI 67 ASH Annual Meeting 67 Digestive Disease Week DDW 67 Society CTOS 67 #th Annual Interscience 66 UEGW 66 Late Breaker 66 ASBMR 66 SABCS 66 AACR San Antonio 66 ECCMID 66 ASGT 66 Endocrine Society Annual Meeting 65 ISPOR 65 Genitourinary Cancers Symposium 65 Prostate Cancer Symposium 65 st Annual Meeting 65 EULAR 65 EASD 64 AAN Annual Meeting 64 nd Annual Meeting 64 Connective Tissue Oncology 64 ASCO GU 64 AUA Annual Meeting 64 Digestive Diseases Week 64 AACR #st Annual Meeting 64 Clinical Oncology Annual Meeting 63 Chicago Multidisciplinary Symposium 63 Biological Therapy 63 Opportunistic Infections CROI 63 Antimicrobial Agents 63 Endocrine Society ENDO 63 EORTC NCI AACR 63 Digestive Disease Week 63 ISHLT 63 Transcatheter Cardiovascular Therapeutics TCT 63 Heart Failure Society 62 ESMO 62 America HFSA 62 Cancers Symposium 62 AHA Scientific Sessions 62 Cancer iSBTc 62 HFSA 62 League Against Rheumatism 62 Rheumatology ACR Annual 62 ASCRS 62 Pediatric Academic Societies PAS 61 Endocrine Society #st 61 CTRC AACR San Antonio 61 ASCO Breast Cancer 61 AACR 61 #st Annual Meeting 61 Alzheimer Disease ICAD 61 EUROGIN 61 Breast Cancer Symposium 61 Transcatheter Cardiovascular Therapeutics 61 AAPM 61 Arteriosclerosis Thrombosis 61 AACR #nd Annual Meeting 61 Hematology ASH 61 Pharmacoeconomics 61 #nd Annual Meeting 61 Experimental Biology EB 61 Rheumatology Annual 61 Oncology ASTRO 61 Nephrology Renal Week 61 EORTC 61 Keystone Symposia 60 ASCO Genitourinary Cancers Symposium 60 Liver Diseases AASLD 60 Retroviruses 60 ECNP 60 Clinical Oncology ASCO Annual 60 AASLD Meeting 60 Therapeutics TCT 60 ECCO ESMO 60 EORTC NCI AACR Symposium 60 IASLC 60 Gastroenterology ACG 60 EFNS 60 www.asco.org 60 #nd EORTC NCI 60 HCV Protease Inhibitor 60 EORTC NCI 60 #th Interscience Conference 60 USpella 60 Neurology AAN 59 Pediatric Academic Societies 59 ongoing Phase 1b 59 HCV SPRINT 59 iSBTc 59 ACR ARHP Annual 59 American Urological Association 59 Vascular Biology ATVB 59 Gynecologic Cancer Society 59 International Papillomavirus 59 Molecular Targets 59 Malignant Mesothelioma 59 Hematology Annual Meeting 59 Hematology Meeting 59 th Interscience Conference 59 BIOCOM Investor Conference 59 www.aacr.org 59 CALGB 59 Clinical Oncologists 59 Hematology ASH Annual Meeting 58 American Thoracic Society 58 ENDO 58 Rheumatology Annual Meeting 58 Endocrine Society #nd 58 Wound Healing Society 58 Liver EASL 58 AACR EORTC NCI 58 Outcomes Research ISPOR 58 Annual Scientific Sessions 58 ASTMH 58 Therapeutics TCT scientific 58 ASGCT 58 Interventional Radiology SIR 58 ASTRO Annual Meeting 58 Liver Diseases 58 Therapeutic Radiation 58 AIR2 Trial 58 Annual Transcatheter Cardiovascular 58 Cambridge Healthtech Institute 58 Clinical Trial Results 58 delafloxacin 58 BIO InvestorForum 58 Liver Disease AASLD 58 Breaking Clinical Trials 58 Chemotherapy ICAAC 58 entitled Synergistic 58 Dr. Yatscoff 58 ASHG 57 Interventions SCAI 57 Stem Cell Research ISSCR 57 Biophysical Society 57 annual Transcatheter Cardiovascular 57 PROSTVAC TM 57 Liver Meeting 57 EVEREST II 57 Clinical Oncology ASCO 57 Molecular Medicine Tri 57 BiTE R 57 Lung Transplantation 57 Gene Therapy ASGT 57 AACR Annual Meeting 57 Antiviral Therapy 57 Cardiovascular Therapeutics 57 SAEM Annual Meeting 57 International Myeloma Workshop 57 Malignant Lymphoma 57 Aggressive Reduction 57 ACNP 57 Scientific Session 57 Fifth Decennial International 57 EuroPCR 57 Oral Presentations 57 Diabetologia 57 Pharmacoepidemiology 57 Phase Ib study 57 Interscience Conference 56 Oligonucleotide Therapeutics Society 56 AAGL 56 Inflammatory Bowel Diseases 56 Preclinical Study 56 Telbivudine 56 Abstract Number 56 Neurology Annual Meeting 56 Pediatric Academic Society 56 Diabetes EASD 56 Solid Tumors 56 ANN INTERN MED 56 VEITHsymposium 56 Clinical Dermatology 56 ABRF 56 ISTH 56 Endocrine Society 56 Phase 1b trial 56 PAINWeek 56 AACR NCI EORTC Molecular 56 Canaccord Adams Hepatitis C 56 SUCCEED trial 56 Hypertension ASH 56 Annual ICAAC 56 CombAT 56 Neuropsychopharmacology 56 Acute Heart Failure 56 Cardiovascular Interventions 56 Therapeutics Roundtable 56 AA Amyloidosis 56 Cell Biology ASCB 56 Oral Presentation 56 OARSI 56 Gastroenterology ACG Annual 56 RTOG 56 Cachexia 56 EXPAREL ™ 56 PROTECT II 56 Poster Presentation 56 NASDAQ SLXP today 56 Neck Surgery Foundation 56 HFSA Annual 56 Poster Discussion 56 ASMBS 56 randomized discontinuation trial 56 Scientific Sessions 56 ERA EDTA 56 www.nejm.org 56 MASCC 56 RE LY trial 56 Poster Presentations 56 AOSSM 56 Plicera 56 oral FTY# 56 II Clinical Trial 56 ORAL Sync 55 Clinical Practice Guideline 55 AAO HNSF Annual Meeting 55 radezolid 55 ISSCR 55 Symposium SABCS 55 ESTRO 55 Podium Presentation 55 Breast Surgeons 55 abstracts summarizing 55 journal Catheterization 55 Medical Oncology ESMO 55 http:/www.genmab.com 55 Clinical Oncology 55 & Immunology AAAAI 55 ATVB 55 Nasdaq ALXN 55 ACAAI 55 Opportunistic Infections 55 AAO HNS 55 BRIM3 55 CIBMTR 55 DDW 55 SAWC WHS 55 Advanced Renal Cell 55 Environ Health Perspect 55 Solorel TM 55 #rd Annual CTRC 55 Selective Cardiac Myosin Activator 55 Phase Ib II 55 Neuropathic Pain 55 Clinical Therapeutics 55 CALGB # [002] 55 Consensus Statement 55 Scientific Meeting 55 Opexa 55 Gynecological Cancer 55 J Clin Oncol 55 teriflunomide 55 Phase #/#a 55 Clinical Virology Symposium 55 SfN 55 ASM Biodefense 55 Menopause Society NAMS 55 Endocrine Practice 55 San Antonio Breast Cancer 55 Lysosomal Disease Network 55 BHIVA 55 Mineral Research ASBMR 55 SPIRIT IV 55 Clinical Oncology Gastrointestinal Cancers 55 Cancer Immunotherapy 55 AABB Annual Meeting 55 liposome injection 55 Autoimmune Disease 55 Clinical Antipsychotic Trials 55 American Psychosomatic Society 55 Natalizumab 55 NFID 55 HUPO 55 Human Genetics ASHG 55 BRIM2 55 Traficet EN 55 Neuro Oncology SNO 55 HyQ 55 Phase III psoriasis 55 SAWC 55 Immunologists 54 AACR IASLC Joint 54 Carfilzomib 54 EACTS 54 Antiviral Activity 54 AVADO 54 DDW ® 54 Autoimmune Diseases 54 Liver Disease 54 CRLX# 54 ACUITY trial 54 ASNR 54 Abstracts 54 American Roentgen Ray 54 Poster Session 54 Nephrology ASN 54 http:/www.hematology.org 54 Pharmaceutical Scientists AAPS 54 Oral Fingolimod 54 Therapeutic Radiology 54 Neuropsychopharmacology ACNP 54 HORIZONS AMI 54 journal Arteriosclerosis Thrombosis 54 INFORMS 54 www.hematology.org 54 SCAI Annual 54 Chronic Heart Failure 54 ESCRS 54 NASDAQ CYTK announced 54 Abstract # 54 FOLOTYN ® 54 Systemic Sclerosis 54 Dr. McHutchison 54 clevidipine 54 Neoplasia 54 HORIZONS AMI trial 54 oral Xeloda 54 Preclinical Data 54 TG MV 54 NSABP 54 sipuleucel T 54 Dr. Pingpank 54 Microbiology ASM 54 Diabetic Macular Edema 54 #th Annual Retrovirus 54 FDA Advisory Panel 54 phase IIb study 54 Glufosfamide 54 Therapeutic Advances 54 HuMax CD4 54 vidofludimus 54 TACI Ig 54 CR# vcMMAE 54 Therapeutic Approaches 54 BCIRG 54 Breast Cancer Symposium SABCS 54 Respiratory Society 54 EchoCRT 54 ENESTnd 54 Physiological Society 54 ASCO abstract 54 histone deacetylase HDAC inhibitor 54 Ophthalmology ARVO 54 GTCbio 54 Am J Pathol 54 Hana Biosciences 54 NAASO 54 ISSWSH 54 Vaccine Immunology 54 Belimumab 54 ACRIN 54 ASCO Gastrointestinal Cancers Symposium 54 JACC Cardiovascular Interventions 54 Clinical Trial Data 54 NEJM 54 Bipolar Disorders 54 Atrial Fibrillation Symposium 54 website www.asco.org 54 Phase IIB 54 Prostate AdenoCarcinoma Treatment 54 ganetespib 54 LymphoStat B 54 BARI 2D 54 Immunology Annual Meeting 54 Arch Neurol 54 Spine Arthroplasty Society 54 topical calcineurin inhibitors 54 viral kinetic 53 MERLIN TIMI 53 ACC.# 53 Selective Cardiac Myosin 53 Gastrointestinal Cancer 53 Phase 2b Clinical Trial 53 Related Disorders ICAD 53 Vascular Annual Meeting 53 Liver Transplantation 53 Clinical Microbiology 53 Arch Surg 53 CLEO QELS 53 viral kinetics 53 rALLy trial 53 AAICAD 53 BioCentury Newsmakers 53 evaluating tivozanib 53 CIRSE 53 Phase III Clinical Trial 53 pharmacokinetic PK study 53 Castration Resistant Prostate Cancer 53 CLARITY study 53 SCDM 53 Cardiology ESC 53 Therapeutic Targets 53 Autoimmunity 53 ISMPP 53 R roscovitine 53 phase IIIb 53 Infectious Diseases Society 53 KRN# 53 SYNTAX trial 53 ASBMB 53 Brentuximab Vedotin SGN 53 Radiation Oncology ASTRO 53 Randomized Phase III 53 ACC AHA 53 Phase Ib clinical 53 Inflammatory Arthritis 53 Hepatocellular Carcinoma 53 GASTRO 53 REGiMMUNE 53 Hematology ASH Meeting 53 www.pranabio.com 53 www.regenerx.com 53 Phase #/#a trial 53 PEG SN# 53 Arch Intern Med 53 cabozantinib 53 CRMD# 53 DermaVir Patch 53 Nasdaq ONXX today 53 INCB# [001] 53 PEGylated interferon beta 1a 53 EGS# 53 MEDCAC 53 HDAC Inhibitor 53 ExTRACT TIMI 53 Phase 2b RESTORE CLI 53 Ophthalmic Drugs Advisory 53 Nasdaq ENZN 53 DIA Annual Meeting 53 Neurological Surgeons AANS 53 Metastatic Melanoma 53 LD Micro 53 Cervical Pathology 53 & OTO EXPO 53 Marrow Transplantation 53 Antimicrobial Chemotherapy 53 th Annual Interscience 53 Epilepsy Society 53 BioProcess International 53 Breaking Clinical Trial 53 Patient Recruitment 53 Randomized Comparison 53 Glucosamine Chondroitin Arthritis 53 Canaccord Genuity Growth 53 Retrovirus 53 Ocular Diseases 53 Trandolapril 53 Cardiostim 53 BioCentury Future Leaders 53 AAAAI 53 Radiation Therapy Oncology 53 Urocortin 2 53 Surgical Pathology 53 Am J Gastroenterol 53 Windhover Therapeutic Area 53 Dr. Gulfo 53 ROCKET AF 53 FDLI 53 prospective multicentre 53 PreCISe 53 Ocrelizumab 53 Telaprevir 53 OneMedForum 53 phase Ib 53 Dose Escalation 53 Molecular Markers 53 Inc. Nasdaq AVRX 53 Urology EAU 53 Diabetic Macular Edema DME 53 BiTE antibody MT# 53 journal Cell Transplantation 53 Combination REOLYSIN R 53 number NCT# ClinicalTrials.gov 53 Tanespimycin 53 AACR Meeting 53 Sangamo BioSciences Announces 53 PROactive Study 53 Gynecologic Oncologists 53 fosbretabulin 53 Amrubicin 53 #:#-# [031] 53 phase IIb trial 53 Zarnestra 53 REG2 53 Breast Surgeons ASBS 53 Romiplostim 53 Continence Society 53 Photocure ASA 53 clinical pharmacology studies 53 AAO HNSF 53 BAL# [002] 53 pan HDAC inhibitor 53 PSN# [002] 52 AIDAC 52 www.annals.org 52 AANS 52 ASN Renal Week 52 Hsp# Inhibitor 52 Intensive Care Medicine 52 See CLINICAL PHARMACOLOGY 52 Edge STudy 52 HuMax EGFr 52 HCV Genotype 52 APEX AMI trial 52 Gynecol Oncol 52 Printable slides 52 Innate Immunity 52 Nordic ACTI 52 Cell Transplant 52 Dr. Fehlings 52 Phase 2a 52 LibiGel ® 52 NIH Consensus 52 depsipeptide 52 recurrent glioma 52 Cardiology Scientific Sessions 52 Cellular Therapy 52 Pharmacotherapy 52 APPRAISE 52 Genta Incorporated OTCBB GETA 52 Echocardiography ASE 52 ENDEAVOR III 52 Developmental Therapeutics 52 journal Hepatology 52 Oncologic Drugs Advisory 52 ANTEGREN 52 Nasdaq CLSN 52 peer reviewed journal Annals 52 NICE SUGAR 52 Relapsing Multiple Sclerosis 52 AIDS Vaccine 52 Double Blind Placebo 52 AAPS Annual Meeting 52 EuroIntervention 52 Chronic Lymphocytic Leukemia 52 FASEB J. 52 NeuroStar TMS Therapy 52 multicenter trials 52 AF Stat 52 Investigative Pathology 52 APTIVUS 52 SNT-MC#/idebenone 52 brivaracetam 52 Pirfenidone 52 BioContact Quebec 52 Clinical Endocrinologists AACE 52 Headache Society 52 Preclinical Studies 52 Clinical Practice Guidelines 52 HoFH 52 Clinicaltrials.gov 52 HDAC Inhibitors 52 phase IIa clinical 52 Nasdaq SGMO announced 52 Quinamed 52 Multicenter 52 Phase 2b Trial 52 AMCP 52 forodesine 52 BIO VentureForum East 52 IADR 52 TMC# C# 52 Clinical Gastroenterology 52 EADV 52 HFES 52 Immunotherapeutic 52 Cardiology ESC Congress 52 Room #AB [002] 52 EMBO Journal 52 EOquin TM 52 AAAAI Annual Meeting 52 ClinicalTrials.gov 52 Molecular Cancer 52 Sipuleucel T 52 Virulizin ® 52 dual endothelin receptor antagonist 52 Endovascular Therapy 52 Androxal TM 52 Hematology 52 Gynecologic Oncology Group 52 Nasdaq IDRA today 52 riociguat 52 ILADS 52 Vaccine Adjuvant 52 TH PO# 52 Controlled Release 52 Phase 2b trial 52 GTCbio 3rd 52 Cancer Therapeutics 52 Ambrisentan 52 Am J Epidemiol 52 American Physiological Society 52 Angiogenesis 52 Phase 2a trial 52 Annual Interscience Conference 52 Dr. Goldknopf 52 Bladder Cancer 52 ELSO 52 Outpatient Setting 52 Inc. Nasdaq VRUS 52 Interventional Cardiologists 52 AACR symposium 52 Acute Ischemic Stroke 52 farletuzumab 52 AADE 52 Hedgehog Pathway Inhibitor 52 PROPEL 52 RhuDex 52 SAGES 52 Hematological Malignancies 52 Nexavar sorafenib 52 COPIC Energy 52 Cancer Therapeutic 52 Blinatumomab 52 ONTARGET 52 phase IIb 52 Medicine SIIM 52 Nasdaq CYCC Nasdaq CYCCP 52 www.thelancet.com 52 Endovascular Therapy ISET 52 NCCN guidelines 52 Talabostat 52 MEND CABG 52 Cardiovascular Renal Physiology 52 Anesthesiologists ASA 52 journal Ophthalmology 52 NSTI Nanotech 52 DSMB 52 Integrative Oncology 52 EFORT Congress 52 VitiGam 52 multicenter Phase II 52 Group RTOG 52 eyeforpharma 52 Intervention Effectiveness 52 Colposcopy 52 Dr. Ayalew Tefferi 52 Retrovirus Conference 52 European CanCer Organisation ECCO 52 NO# [002] 52 ISCT 52 CTRC AACR 51 Pressure Ulcer Advisory Panel 51 Biennial Meeting 51 ESHRE 51 Oncologic 51 CAMMS# 51 J Am Coll 51 Dr. Agarwala 51 Phase 1a clinical 51 Aflibercept 51 AVERROES 51 Valopicitabine 51 OLYMPIA registry 51 Cardiovascular Disease Epidemiology 51 Cellular Therapy ISCT 51 Simulect 51 SYMMETRY trial 51 Intervention Effectiveness CATIE 51 Phase 2a clinical 51 Cardiology ACC 51 REACH Registry 51 LT NS# 51 atacicept 51 journal Transplantation 51 NeuroImage 51 CTAP# Capsules 51 WOCN 51 Neuro Oncology 51 Human Brain Mapping 51 FOLPI 51 PEARL HF 51 Diabetic Neuropathy 51 via Wiley InterScience 51 EULAR Annual 51 Elvitegravir 51 genitourinary cancers 51 Biodetection Technologies 51 compound AEZS 51 Gastric Cancer 51 Phase III ALLEGRO 51 ISPE 51 SWOG 51 Female Urology 51 Hedgehog antagonist 51 enzastaurin 51 Genvec 51 BAL# [001] 51 recurrent glioblastoma multiforme 51 Dr. Blobel 51 Molecular Pathology AMP 51 Drugs Affecting Lipid 51 Capsule Endoscopy 51 Endoscopic Surgeons SAGES 51 http:/www.staar.com 51 Autism Consortium 51 oral ridaforolimus 51 First Patient Enrolled 51 prospective multicenter study 51 YONDELIS R 51 mRCC 51 Aryplase 51 TMS Therapy 51 XL# SAR# 51 Clinical Chemistry AACC 51 PCK# 51 Acute Treatment 51 www.acc.org 51 FDA Oncologic Drugs 51 Xinlay 51 Microplasmin 51 RESTORE CLI 51 ® DDW 51 Zenvia Phase III 51 Investor Luncheon 51 Chemophase 51 abstr 51 Nat Genet 51 AAAS Annual Meeting 51 ENDEAVOR IV 51 Immune Mediated 51 Retina Specialists 51 AACR Frontiers 51 Molecular Therapy 51 Stent Thrombosis 51 ON #.Na 51 Molecular Origins 51 Infectious Diseases ECCMID 51 Ann Oncol 51 journal Nature Immunology 51 Healthcare Epidemiology 51 HQK 51 Prospective Randomized 51 Pooled Analysis 51 Pharmacological Society 51 NASDAQ CXSP announced 51 Thoracic Oncology 51 Hydroxyurea 51 IL# PE#QQR 51 CTI Nasdaq 51 Randomized Double Blind 51 MADIT CRT 51 eltrombopag 51 YONDELIS 51 Clinical Efficacy 51 aldosterone antagonists 51 ACM SIGCOMM 51 Windhover Information 51 Neck Cancer 51 PFO migraine 51 J. Mazzo Ph.D. 51 Phase Ib Clinical Trial 51 Venereology EADV 51 Nephrology ASN Renal 51 Allovectin 7 ® 51 ARVO Annual Meeting 51 Vascular Disease 51 CUSTOM II 51 Placebo Controlled Trial 51 SIIM 51 Elagolix 51 multicenter randomized Phase 51 NABTT 51 AAEP Convention 51 Immunology ACAAI 51 HDL Selective Delipidation 51 multicenter prospective 51 Haemostasis 51 Refractory Angina 51 Bortezomib 51 EAACI 51 #:# -# [003] 51 Targeted Anticancer Therapies 51 Heart Assn 51 NeoRecormon 51 pediatric acute lymphoblastic 51 abstracts 51 randomized Phase III 51 Pulmonary Hypertension 51 journal Nature Reviews 51 Intervention Trial GAIT 51 MedPredict 51 BOLDER II 51 velafermin 51 http:/www.ncbi.nlm.nih.gov/pubmed/# 51 Movement Disorder 51 Archived webcasts 51 Cancer Vaccines 51 Long Awaited Reality 51 CA4P 51 pharmacokinetic PK 51 recurrent GBM 51 TLR antagonist 51 Dr. Siegall 51 Antibody Therapeutics 51 Febuxostat 51 Hemodialysis Patients 51 Thiovir 51 Biodefense Vaccines 51 Epilepsia 51 Cardiovascular Anesthesiologists 51 Annual Meeting 51 Hormone Refractory Prostate Cancer 51 Obes Res 51 dose escalation trial 51 Inc. Nasdaq AMLN 51 mitogen activated ERK kinase 51 multicenter phase 51 Myelodysplastic Syndromes 51 Emergency Medicine SAEM 51 RE LY 51 AGBT 51 Ann Rheum Dis 51 journal Biomacromolecules 51 DU #b 51 Tumor Microenvironment 51 Vitro Activity 51 Diabetic Foot 51 ASA CSSA SSSA 51 REALITY Trial 51 BoNTA 51 Deforolimus 51 APOPTONE 51 Haemostasis ISTH 51 dose escalation clinical 51 NACFC 51 Randomized Phase 51 Lipid Lowering Treatment 50 General Psychiatry #:#-#,# 50 Bone Marrow Transplantation 50 INSPIRE Trial Phase III 50 Dalbavancin 50 American Psychiatric Assn 50 Angiolix 50 MidAtlantic Employers Association 50 Cutaneous T 50 chromium supplementation 50 Varespladib 50 #:# -# [004] 50 Long Term Efficacy 50 nonrandomized studies 50 Rheumatology 50 HIF PHI 50 Decitabine 50 telebriefing 50 Chronix 50 NEJM.org 50 www.delcath.com 50 International Neuropsychological Society 50 www.durect.com 50 Immunogenicity 50 Pharmacoeconomic 50 Immunology AAAAI 50 Romidepsin 50 Boceprevir 50 Phase Ib 50 Safinamide 50 Nasdaq PCYC 50 Group ECOG 50 Elisabeth Lindner CEO 50 Outcome Sciences 50 Related Viruses 50 Respiratory Viral Infections 50 OHR/AVR# 50 Candesartan 50 vismodegib 50 ZFP Therapeutic 50 NCCN Drugs 50 Ann Intern Med 50 preclinical pharmacokinetic 50 Pharmacokinetics 50 decitabine 50 Renal Cell Carcinoma RCC 50 Tumor Biology 50 relapsed MM 50 Bazedoxifene 50 ABCSG 50 evaluating REVLIMID 50 Refractive Surgery ASCRS 50 LUMINATE 50 Fondaparinux 50 varespladib 50 imatinib resistance 50 Inc. Nasdaq MLNM 50 rALLy clinical trial 50 #:#-# [033] 50 BMC Musculoskeletal Disorders 50 Canaccord Adams Healthy Living 50 BiTE 50 Anticoagulation 50 Hematologic Malignancies 50 #-# Full Text 50 JAMA #:#-# 50 TAXUS ATLAS 50 ASCEND HF 50 PI3 kinase inhibitors 50 Windhover Conferences 50 Recurrent Chest Wall 50 Molecular Psychiatry 50 Cytokines 50 Major Depressive Disorder 50 Novel Therapeutics 50 Randomized Phase II 50 romidepsin 50 Randomized Double blind 50 FOCIS 50 Br J Cancer 50 Clinical Psychology Review 50 Phase 1b 50 PROVENGE sipuleucel T 50 Hyperlipidemia 50 Cimzia ® certolizumab pegol 50 randomized multicenter trial 50 alvimopan 50 Rheumatologists 50 Society ILADS 50 Int J Epidemiol 50 Eamonn Quigley 50 verteporfin 50 AVAX 50 transthyretin TTR mediated amyloidosis 50 Phase III ADT 50 Lung Cancer IASLC 50 prospective observational cohort 50 Juergen Engel Ph.D. 50 PTNS 50 Systematic Review 50 Human Proteome Organization 50 BioPharm America 50 ASCB 50 journal Transfusion 50 J Rheumatol 50 ILLUMINATE 50 targeting CD# 50 Nasdaq DNDN 50 ImmuKnow assay 50 LUX Lung 50 Alzhemed TM 50 phase IIa 50 Syndax 50 NCIC CTG 50 tasocitinib 50 Ovarian PLCO Cancer 50 SMi 50 Abiraterone Acetate 50 Diabetes Complications 50 STRIDE PD 50 Egrifta 50 CardioBip 50 Cardiotoxicity 50 DAVANAT 50 preclinical efficacy 50 Diasome 50 ALLHAT 50 Allergology 50 Kidney Int 50 INCB# [002] 50 Suppl. 50 Canaccord Adams Musculoskeletal 50 TRO# 50 PLCO 50 Fabry Disease 50 IMiDs ® compound 50 Cardiovascular Angiography 50 Hagop M. 50 orally inhaled migraine 50 Teriflunomide 50 Rexahn Pharmaceuticals 50 Investigational Drug 50 Hand ASSH 50 randomized controlled Phase 50 Fondation Ipsen 50 journal Diabetologia 50 Venous Forum 50 Immunodeficiencies 50 journal Pediatric Allergy 50 placebo controlled clinical 50 PRECISE trial 50 Interstitial Cystitis 50 Peer Reviewed Journal 50 Oral Session 50 Investigative Dermatology 50 TASKi2 50 cardio renal